Isolex 300i CD34^-selected cells to support multiple cycles of high-dose therapy

By Prince HM   Bashford J   Wall D   Rischin D   Parker N   Toner GC   Seymour JF   Blakey D   Haylock D   Simmons P   Francis P   Wolf M   Januszewicz EH   Richardson G   Scarlett J   Briggs P  

Cytotherapy, Vol. 4, Iss. 2, 2002-03 ,pp. : 137-145

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Improved immunomagnetic enrichment of CD34 ⁺ cells from umbilical cord blood using the CliniMACS cell separation system

By Blake Joseph M.   Nicoud Ian B.   Weber Daniel   Voorhies Howard   Guthrie Katherine A.   Heimfeld Shelly   Delaney Colleen  

Cytotherapy, Vol. 14, Iss. 7, 2012-08 ,pp. : 818-822

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Evaluation of 'out-of-specification' CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products

By Braakman E.   Schuurhuis Gj   Preijers Fwmb   Voermans C.   Theunissen K.   van Riet I.   Fibbe We   Slaper-Cortenbach I.  

Cytotherapy, Vol. 10, Iss. 1, 2007-12 ,pp. : 83-89

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133+ and CD34+ cells

By Lu X.   Baudouin SV   Gillespie JI   Anderson JJ   Dickinson AM  

Cytotherapy, Vol. 9, Iss. 3, 2007-01 ,pp. : 292-300

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Use of selected CD34⁺ cells in the treatment of relapsed/progressive HD: experiences from a single center

By Lakota J   Ballová V   Drgoňa L'   Ďurkovič P   Vranovský A  

Cytotherapy, Vol. 4, Iss. 2, 2002-03 ,pp. : 177-180

Ashgate Publishing Ltd

Access to resources Recommend Favorite